Fundamental Analysis of BIOMERICA INC(NASDAQ:BMRA) stock

Fundamental Rating

Taking everything into account, BMRA scores 2 out of 10 in our fundamental rating. BMRA was compared to 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of BMRA is average, but there are quite some concerns on its profitability. BMRA has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

BMRA had negative earnings in the past year.

In the past year BMRA has reported a negative cash flow from operations.

BMRA had negative earnings in each of the past 5 years.

BMRA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of BMRA (-78.30%) is worse than 79.14% of its industry peers.

The Return On Equity of BMRA (-115.26%) is worse than 69.52% of its industry peers.

		Industry Rank	Sector Rank
ROA	-78.3%
ROE	-115.26%
ROIC	N/A

ROA(3y)-51.28%

ROA(5y)-46.48%

ROE(3y)-68.67%

ROE(5y)-61.12%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of BMRA (8.81%) is worse than 83.42% of its industry peers.

BMRA's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for BMRA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	8.81%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y29.97%

GM growth 5Y-14.58%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BMRA does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for BMRA remains at a similar level compared to 1 year ago.

BMRA has more shares outstanding than it did 5 years ago.

There is no outstanding debt for BMRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

BMRA has an Altman-Z score of -8.89. This is a bad value and indicates that BMRA is not financially healthy and even has some risk of bankruptcy.

BMRA's Altman-Z score of -8.89 is on the low side compared to the rest of the industry. BMRA is outperformed by 79.14% of its industry peers.

There is no outstanding debt for BMRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-8.89

ROIC/WACCN/A

WACC9.07%

2.3 Liquidity

A Current Ratio of 3.00 indicates that BMRA has no problem at all paying its short term obligations.

The Current ratio of BMRA (3.00) is comparable to the rest of the industry.

BMRA has a Quick Ratio of 2.09. This indicates that BMRA is financially healthy and has no problem in meeting its short term obligations.

The Quick ratio of BMRA (2.09) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	3
Quick Ratio	2.09

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BMRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.78%, which is quite good.

Looking at the last year, BMRA shows a small growth in Revenue. The Revenue has grown by 1.79% in the last year.

Measured over the past years, BMRA shows a small growth in Revenue. The Revenue has been growing by 0.81% on average per year.

EPS 1Y (TTM)12.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-11.76%

Revenue 1Y (TTM)1.79%

Revenue growth 3Y-9.06%

Revenue growth 5Y0.81%

Sales Q2Q%5.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BMRA. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BMRA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BIOMERICA INC

NASDAQ:BMRA (11/22/2024, 4:30:01 PM)

0.314

-0.01 (-2.94%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap5.28M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-78.3%
ROE	-115.26%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	8.81%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.7

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	3
Quick Ratio	2.09
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)12.78%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next YN/A

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)1.79%

Revenue growth 3Y-9.06%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

BIOMERICA INC (BMRA)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens